XOMA Initiates Pilot Trial Studying Gevokizumab in Patients With Pyoderma ... PipelineReview.com (press release) BERKELEY, CA, USA I June 13, 2013 I XOMA Corporation (XOMA), a leader in the discovery and development of therapeutic antibodies, today announced it has opened enrollment in a pilot study to determine gevokizumab's potential to treat acute ... |
